New Jersey Medicinal Marijuana Review Panel Recommends Adding Chronic Pain, Migraine, Anxiety and Tourette’s Syndrome to List of Qualifying Conditions

Advocates Applaud Panel Recommendation and Look Forward to Health Commissioner’s Decision New Jersey Should Join Other States That Allow Medical Marijuana for Chronic Pain Trenton, NJ— Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain, migraine, anxiety and Tourette’s Syndrome as qualifying conditions for […]

Read More

Cannabis Might Be the Next Migraine Drug

A recent review of medical literature, courtesy of the Headache Center at the Cleveland Clinic Neurological Institute in Cleveland, Ohio, has shown that cannabis has potential therapeutic effects for the treatment of headache disorders, including migraines. Read article here: High Times

Read More